p53 Immunohistochemistry for Distinguishing Reactive Mesothelium from Low Grade Ovarian Carcinoma | Citedby Results | Acta Cytologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

p53 Immunohistochemistry for Distinguishing Reactive Mesothelium from Low Grade Ovarian Carcinoma

Acta Cytologica (2000) 44 (1): 31–36.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Diagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions

Nesreen H. Hafez
Neveen S. Tahoun

Journal of the Egyptian National Cancer Institute (2011) 23 (4): 155.

Evaluation of apoptosis in cytologic specimens

Viktor Shtilbans
Maoxin Wu
David E. Burstein

Diagnostic Cytopathology (2010) 38 (9): 685.

Effusion cytology: Keeping researchers and journals in business for the past 20 years—and it is not over yet

Robert L. Zimmerman

Current Diagnostic Pathology (2005) 11 (3): 194.

Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis

Ben Davidson
Björn Risberg
Reuven Reich
Aasmund Berner

Clinics in Laboratory Medicine (2003) 23 (3): 729.

The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions

Peter B. Illei
Marc Ladanyi
Valerie W. Rusch
Maureen F. Zakowski

Cancer (2002) 99 (1): 51.

mRNA detection of tumor-rejection genes BAGE, GAGE, and MAGE in peritoneal fluid from patients with ovarian carcinoma as a potential diagnostic tool

Manfred Hofmann
Ilka Ruschenburg

Cancer (2002) 96 (3): 187.

Glucose Transporter Glut-1 Is of Limited Value for Detecting Breast Carcinoma in Serous Effusions

Robert L Zimmerman
Shanth Goonewardene
Franz Fogt

Modern Pathology (2001) 14 (8): 748.